Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Jeff Collins to serve as a judge for the 2nd Carolina Entrepreneurial Initiative Challenge
News | 04. 22. 2006
